MedTrace Logo

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects

NCT01171664 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-03-26

No results posted yet for this study

Summary

To report and compare total symptom scores, nasal symptom scores, post-nasal drip symptom scores, and adverse reactions in and between SAR subjects on active drug and SAR subjects on placebo.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Placebo

Tablet, one BID

DRUG

STAHIST

STAHIST in tablet form dosed one BID

Sponsors & Collaborators

  • Magna Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen J Pollard, MD · Family Allergy & Asthma Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171664 on ClinicalTrials.gov